Grayzel David S. Insider Trades

Insider Trading History

Track insider trading activity for Grayzel David S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $199k 16,363 shares
Last Trade
Jan 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.9k 16,363 shares
$3.60
$12.19
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $652k 53,521 shares
Last Trade
Oct 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 53,521 shares
$2.80
$12.19
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $227k 18,595 shares
Last Trade
Feb 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.2k 33,931 shares
$2.54
$12.19
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$86.2k 33,931 shares
$2.54
$12.19
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $227k 18,595 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.5k 18,595 shares
$3.20
$12.19
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $33.5k 12,500 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.27M 12,500 shares
$661.50
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $38.9k 14,502 shares
Last Trade
Apr 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7M 11,882 shares
$981.75
$2.68
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $31.3k 2,569 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 2,569 shares
$18.00
$12.19
Q32 Bio
Q32 Bio QTTB
Director
Holding Value $156k 12,767 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 12,767 shares
$0.93
$12.19
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $8.54k 3,186 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.43M 3,186 shares
$763.35
$2.68
Surface Oncology
Surface Oncology SURF
Director
Holding Value $0 0 shares
Last Trade
Sep 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.15M 2,945,453 shares
$1.07
$1.07
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $33.5k 12,500 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.13M 12,500 shares
$570.50
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $7.11k 2,654 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.51M 2,654 shares
$946.05
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $33.5k 12,500 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.36M 12,500 shares
$429.10
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $33.5k 12,500 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.36M 12,500 shares
$429.10
$2.68
Surface Oncology
Surface Oncology SURF
Director
Holding Value $25.7k 24,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.2k 24,000 shares
$2.01
$1.07
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $19.6k 7,317 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.8M 7,317 shares
$382.55
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $8.32M 3,103,879 shares
Last Trade
Jul 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$374M 535,714 shares
$697.90
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $6.88M 2,568,165 shares
Last Trade
Jul 02, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.79B 2,568,165 shares
$697.90
$2.68
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $0 0 shares
Last Trade
Jul 02, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$5.57B 7,976,754 shares
$697.90
$2.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up